Intelligence Infrastructure

Data Sources

Vantro's market intelligence is built on primary source data from multilateral organisations, national regulatory authorities, and practitioner-verified market analysis. Every data point is source-cited and carries a last-verified date.

Multilateral Organisations
WHO Global Health Observatory
Health system indicators, UHC coverage, disease burden data
World Bank Open Data
GDP, healthcare expenditure, ease of doing business indicators
UNICEF Supply Division
Procurement volumes, product categories, supplier and pricing data
UNDP Human Development Reports
Market context and development indicators
WHO Prequalification Programme
Prequalified product lists, assessment timelines, supplier data
Global Fund Procurement Data
Country programme procurement data, eligible product categories
GAVI Supply and Procurement
Vaccine procurement structures and co-financing models
UNCTAD TRAINS
Tariff and non-tariff measure data for customs analysis
National Regulatory & Customs Authorities
CountryRegulatory AuthorityCustoms / Revenue AuthorityVerified
Saudi Arabia
SFDA
Device & drug registration, CE/510(k) reliance, NUPCO procurement
Q1 2026
UAE
MOHAP
Registration, classification, DHA/HAAD free zone rules
Q1 2026
Qatar
MOPH Qatar
Registration, pricing, Hamad Medical procurement
Q1 2026
Kuwait
MOPH Kuwait
Registration requirements, public procurement channels
Q1 2026
Jordan
JFDA
Registration, CE reliance, pricing controls
Q1 2026
Turkey
TITCK
Device registration, SGK reimbursement, local partner rules
Q1 2026
Egypt
EDA
Device registration, pricing controls, CE reliance partial
Q1 2026
Morocco
DMP / MoH
Registration, EMA/CE reliance, SEGMA procurement
Q1 2026
Kenya
PPB Kenya
Device registration, WHO CRP pathway, KEMSA procurement
Q1 2026
Nigeria
NAFDAC
Registration 12–24mo, WHO PQ for public sector, local content rules
Q1 2026
South Africa
SAHPRA
CE/EU MDR reliance pathways, Section 21 authorisation
Q1 2026
Ghana
FDA Ghana
Device & drug registration, CE reliance, procurement pathways
Q1 2026
Ethiopia
EFDA
Registration requirements, public procurement channels
Q1 2026
Tanzania
TMDA
6–12mo registration, MSD procurement, USAID/Global Fund channels
Q1 2026
Rwanda
Rwanda FDA
3–6mo for WHO-PQ products, RMS procurement
Q1 2026
Senegal
DPM / DPMED
CAMICS procurement, UEMOA reliance pathway
Q1 2026
Uganda
NDA Uganda
Device registration, NMS procurement, EAC reliance
Q1 2026
Zambia
ZAMRA
Device & drug registration, Medical Stores procurement
Q1 2026
Côte d'Ivoire
DGPHP / WAEMU
Registration, UEMOA reliance, PNSP procurement
Q1 2026
India
CDSCO
Medical device rules 2017, NPPA price controls, UNICEF channel
Q1 2026
Bangladesh
DGDA
Device & drug registration, CMSD procurement
Q1 2026
Pakistan
DRAP
Device registration, pricing controls, PPHI procurement
Q1 2026
Nepal
DoDA Nepal
Registration requirements, public procurement channels
Q1 2026
Bhutan
DRA Bhutan
Device & drug registration, Essential Medicines procurement
Q1 2026
Vietnam
DAV / MOH
Registration classes, reliance pathways, class C/D backlog
Q1 2026
Thailand
FDA Thailand
Device classification, GPO procurement, CE reliance
Q1 2026
Indonesia
BPOM
Device/drug registration, halal cert, complex geography
Q1 2026
Philippines
FDA Philippines
Registration, CE reliance, PhilHealth/JKN procurement
Q1 2026
China
NMPA
Class III 12–18mo, VBP procurement, local JV often required
Q1 2026
Brazil
ANVISA
Sanitary registration, SUS procurement, Mercosur reliance
Q1 2026
Mexico
COFEPRIS
Registration, IMSS/ISSSTE tenders, local partner required
Q1 2026
Colombia
INVIMA
Device & drug registration, SGSSS procurement
Q1 2026
Peru
DIGEMID
Registration, SIS procurement, CE reliance partial
Q1 2026
Argentina
ANMAT
Device registration, PAMI/Obras Sociales procurement
Q1 2026
Chile
ISP
Registration, CENABAST procurement, CE reliance
Q1 2026
Canada
Health Canada
Class II 90-day review, MRA reliance for FDA-cleared devices
Q1 2026
European Union
EMA / National CAs
CE Mark EU MDR 2017/745, notified body, IVDR for IVD
Q1 2026
Market Intelligence

Procurement structure data, tender cycle timing, pricing framework analysis, and local partner requirement details are compiled and continuously verified by global health market access practitioners with direct experience working across these markets for WHO, UNICEF, Bloomberg Philanthropies, and the World Bank. Timeline estimates reflect actual review durations tracked from submission to approval — not authority-published targets, which frequently understate real processing time.

Update Frequency
Market tierVerification cadence
Priority markets
Saudi Arabia, UAE, India, Vietnam, Philippines
Quarterly verification
Secondary markets
Indonesia, Kenya, South Africa, Nigeria, Egypt, Ghana, Ethiopia, Bangladesh, Thailand, Turkey, Morocco
Semi-annual verification
Extended coverage
Colombia, Peru, Argentina, Chile, Jordan, Kuwait, Tanzania, Rwanda, Senegal, Uganda, Zambia, Nepal, Bhutan, Côte d'Ivoire
Annual verification
All markets
On confirmed regulatory change
Immediate update
Last full verification
February 2026
Data Limitations

Regulatory environments change frequently across international markets. Vantro makes every effort to maintain current, accurate data but cannot guarantee completeness or accuracy for all product categories in all markets. Users should treat Vantro dimension ratings as directional intelligence and engage qualified local regulatory consultants for formal market entry decisions.